Implantable Cardioverter Defibrillators (ICD) – Medical Devices Pipeline Assessment, 2020

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses. GlobalData's Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Implantable Cardioverter Defibrillators (ICD) Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Implantable Cardioverter Defibrillators (ICD) pipeline products.

Review of Recent Developments in the segment / industry

The Implantable Cardioverter Defibrillators (ICD) Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Implantable Cardioverter Defibrillators (ICD)- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Advanced BioInformatics GmbH

AIS Inc.

Boston Scientific Corp

CardiaLen, Inc.

Coridea, LLC

InnerPulse Inc (Inactive)

Johns Hopkins University

Kenergy Inc.

Massachusetts General Hospital

Max Planck Institute for Dynamics and Self-Organization

Medicool Technologies Inc

Medtronic Plc

MicroPort CRM

Smartwave Medical Ltd (Inactive)

Suzhou Wushuang Medical Equipment Co Ltd

Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Implantable Cardioverter Defibrillators (ICD) Overview 6

3 Products under Development 7

3.1 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 7

3.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 8

3.3 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 9

3.4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 10

3.5 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 11

3.6 Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 12

4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products under Development by Companies 13

4.1 Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development 13

4.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 14

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 15

5.1 Advanced BioInformatics GmbH Company Overview 15

5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 AIS Inc. Company Overview 16

5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Boston Scientific Corp Company Overview 17

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 CardiaLen, Inc. Company Overview 23

5.4.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Coridea, LLC Company Overview 26

5.5.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 InnerPulse Inc (Inactive) Company Overview 27

5.6.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Johns Hopkins University Company Overview 28

5.7.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Kenergy Inc. Company Overview 29

5.8.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Massachusetts General Hospital Company Overview 30

5.9.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Max Planck Institute for Dynamics and Self-Organization Company Overview 32

5.10.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Medicool Technologies Inc Company Overview 33

5.11.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Medtronic Plc Company Overview 34

5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 MicroPort CRM Company Overview 39

5.13.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Smartwave Medical Ltd (Inactive) Company Overview 46

5.14.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.15 Suzhou Wushuang Medical Equipment Co Ltd Company Overview 47

5.15.1 Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 48

6.1 May 08, 2020: First Direct Comparison of ICD Devices Underscores Benefits of the S-ICD with Better Safety Profile and Fewer Device-Related Complications 48

6.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 49

6.3 Feb 27, 2020: Philips and the European Society of Radiology to host Ultrasound Academy at ECR 2020 49

6.4 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 50

6.5 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 50

6.6 Feb 18, 2020: Medtronic reports third quarter financial results 2020 51

6.7 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 53

6.8 Jan 28, 2020: Philips' fourth quarter and annual results 2019 55

6.9 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 59

6.10 Jan 06, 2020: Philips expands its range of consumer-focused digital health solutions at CES 2020 60

6.11 Dec 17, 2019: Philips to nominate Feike Sijbesma and Peter Löscher as members of the Supervisory Board 62

6.12 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 62

6.13 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 63

6.14 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 65

6.15 Oct 30, 2019: CONMED announces third quarter 2019 financial results 66

6.16 Oct 28, 2019: Philips delivers Q3 sales of EUR

4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of

12.4% 67

6.17 Oct 28, 2019: Philips' third quarter results 2019 69

6.18 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 71

6.19 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 73

6.20 Oct 10, 2019: Philips provides update on its financial performance in Q3 2019 74

6.21 Oct 07, 2019: Medtronic initiates worldwide pivotal study of a new approach to treating dangerously fast heart rhythms 74

7 Appendix 76

7.1 Methodology 76

7.2 About GlobalData 80

7.3 Contact Us 80

7.4 Disclaimer 80

List of Tables

Table 1: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 7

Table 2: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 8

Table 3: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 9

Table 4: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 10

Table 5: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 11

Table 6: Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 12

Table 7: Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development 13

Table 8: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 14

Table 9: Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 15

Table 10: Cardiac Rhythm Management Device – Product Status 15

Table 11: Cardiac Rhythm Management Device – Product Description 15

Table 12: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 16

Table 13: Guardian – Product Status 16

Table 14: Guardian – Product Description 16

Table 15: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17

Table 16: EMBLEM MRI S-ICD System – Aged Patients – Product Status 17

Table 17: EMBLEM MRI S-ICD System – Aged Patients – Product Description 18

Table 18: S-ICD System 1.5 – Product Status 18

Table 19: S-ICD System 1.5 – Product Description 18

Table 20: S-ICD System 2.0 – Product Status 19

Table 21: S-ICD System 2.0 – Product Description 19

Table 22: VITALITY NXT Defibrillator – Product Status 19

Table 23: VITALITY NXT Defibrillator – Product Description 20

Table 24: Boston Scientific Corp – Ongoing Clinical Trials Overview 21

Table 25: EMBLEM MRI S-ICD System – Aged Patients – Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 22

Table 26: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

Table 27: MultiPulse Therapy Device – Product Status 23

Table 28: MultiPulse Therapy Device – Product Description 23

Table 29: CardiaLen, Inc. – Ongoing Clinical Trials Overview 24

Table 30: MultiPulse Therapy Device – A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-energy Therapy in Patients with Atrial Fibrillation Energy Therapy in Patients with Atrial Fibrillation 25

Table 31: MultiPulse Therapy Device – An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF 25

Table 32: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Table 33: Table-Top PaDe System – Product Status 26

Table 34: Table-Top PaDe System – Product Description 26

Table 35: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

Table 36: PICD – Product Status 27

Table 37: PICD – Product Description 27

Table 38: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 28

Table 39: Cardiac Sock Electrode And Implantable Defibrillator System – Product Status 28

Table 40: Cardiac Sock Electrode And Implantable Defibrillator System – Product Description 28

Table 41: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 42: Unconditional MRI Compatible Implantable Defibrillator – Product Status 29

Table 43: Unconditional MRI Compatible Implantable Defibrillator – Product Description 29

Table 44: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

Table 45: Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Status 30

Table 46: Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Description 30

Table 47: Vagal Stimulation ICD Device – Product Status 31

Table 48: Vagal Stimulation ICD Device – Product Description 31

Table 49: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 32

Table 50: Implantable Defibrillator – Product Status 32

Table 51: Implantable Defibrillator – Product Description 32

Table 52: Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 53: Implantable Defibrillator – Product Status 33

Table 54: Implantable Defibrillator – Product Description 33

Table 55: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 34

Table 56: Chronicle ICD – Product Status 34

Table 57: Chronicle ICD – Product Description 35

Table 58: EV-ICD System – Product Status 35

Table 59: EV-ICD System – Product Description 36

Table 60: Medtronic Plc – Ongoing Clinical Trials Overview 37

Table 61: EV-ICD System – Extravascular ICD Pilot Study 38

Table 62: EV-ICD System – Extravascular ICD Pivotal Study: EV ICD 38

Table 63: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 39

Table 64: NAVIGO 4LV 2D – Product Status 39

Table 65: NAVIGO 4LV 2D – Product Description 39

Table 66: NAVIGO 4LV ARC – Product Status 40

Table 67: NAVIGO 4LV ARC – Product Description 40

Table 68: NAVIGO 4LV PILOT – Product Status 40

Table 69: NAVIGO 4LV PILOT – Product Description 41

Table 70: MicroPort CRM – Ongoing Clinical Trials Overview 42

Table 71: NAVIGO 4LV 2D – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 43

Table 72: NAVIGO 4LV ARC – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 44

Table 73: NAVIGO 4LV PILOT – Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 45

Table 74: Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

Table 75: Fully Automatic Implantable Atrial Defibrillator – Product Status 46

Table 76: Fully Automatic Implantable Atrial Defibrillator – Product Description 46

Table 77: Suzhou Wushuang Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Table 78: Implantable Cardioverter Defibrillator – Product Status 47

Table 79: Implantable Cardioverter Defibrillator – Product Description 47

Table 80: Glossary 79

List of Figures

Figure 1: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 7

Figure 2: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 8

Figure 3: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 9

Figure 4: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 10

Figure 5: Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 11

Figure 6: Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 12

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports